MX337358B - Conjugados de disorazoles y sus derivados con moleculas de union con celulas, nuevos derivados de disorazol, procesos de fabricacion y usos de los mismos. - Google Patents

Conjugados de disorazoles y sus derivados con moleculas de union con celulas, nuevos derivados de disorazol, procesos de fabricacion y usos de los mismos.

Info

Publication number
MX337358B
MX337358B MX2011010178A MX2011010178A MX337358B MX 337358 B MX337358 B MX 337358B MX 2011010178 A MX2011010178 A MX 2011010178A MX 2011010178 A MX2011010178 A MX 2011010178A MX 337358 B MX337358 B MX 337358B
Authority
MX
Mexico
Prior art keywords
derivatives
conjugates
disorazoles
processes
cell
Prior art date
Application number
MX2011010178A
Other languages
English (en)
Inventor
Eckhard Günther
Klaus Paulini
Michael Teifel
Olaf Shaefer
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Publication of MX337358B publication Critical patent/MX337358B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se refiere a conjugados de disorazoles y sus derivados con moléculas de unión con células, tales como péptidos, proteínas, hormonas, proteínas sanguíneas y anticuerpos. La presente invención también proporciona nuevos derivados de disorazol y procesos para fabricar estos conjugados y derivados de disorazol. Estos compuestos pueden ser usados como medicamentos para el tratamiento de condiciones fisiológicas y/o patofisiológicas en mamíferos, particularmente para el tratamiento de diversos tumores.
MX2011010178A 2006-09-06 2007-09-06 Conjugados de disorazoles y sus derivados con moleculas de union con celulas, nuevos derivados de disorazol, procesos de fabricacion y usos de los mismos. MX337358B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84235706P 2006-09-06 2006-09-06
EP06018750A EP1900742A1 (en) 2006-09-07 2006-09-07 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
PCT/EP2007/059310 WO2008028934A1 (en) 2006-09-06 2007-09-06 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof

Publications (1)

Publication Number Publication Date
MX337358B true MX337358B (es) 2016-02-29

Family

ID=37670733

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009002483A MX2009002483A (es) 2006-09-06 2007-09-06 Conjugados de disorazolas y sus derivados con moleculas de union con celulas, nuevos derivados de disorazola, procedimientos para fabricarlos y usos de los mismos.
MX2011010178A MX337358B (es) 2006-09-06 2007-09-06 Conjugados de disorazoles y sus derivados con moleculas de union con celulas, nuevos derivados de disorazol, procesos de fabricacion y usos de los mismos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2009002483A MX2009002483A (es) 2006-09-06 2007-09-06 Conjugados de disorazolas y sus derivados con moleculas de union con celulas, nuevos derivados de disorazola, procedimientos para fabricarlos y usos de los mismos.

Country Status (16)

Country Link
US (3) US7741277B2 (es)
EP (2) EP1900742A1 (es)
KR (1) KR101532966B1 (es)
AR (1) AR062685A1 (es)
AU (1) AU2007293650B2 (es)
CA (1) CA2662308C (es)
DK (1) DK2066679T3 (es)
ES (1) ES2572183T3 (es)
HU (1) HUE028061T2 (es)
MX (2) MX2009002483A (es)
NZ (1) NZ575032A (es)
PL (1) PL2066679T3 (es)
RS (1) RS54857B1 (es)
SI (1) SI2066679T1 (es)
TW (1) TWI346116B (es)
WO (1) WO2008028934A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1900742A1 (en) 2006-09-07 2008-03-19 AEterna Zentaris GmbH Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
WO2010033224A1 (en) * 2008-09-19 2010-03-25 Nektar Therapeutics Polymer conjugates of kiss1 peptides
EP2350118B1 (en) 2008-09-19 2016-03-30 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
WO2010096175A1 (en) * 2009-02-20 2010-08-26 Ipsen Pharma S.A.S. Cytotoxic conjugates having neuropeptide y receptor binding compound
US20120004182A1 (en) * 2010-07-02 2012-01-05 Carsten Gruendker Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells
CN114966050A (zh) * 2012-03-18 2022-08-30 镜株式会社 疾病样品分析装置、分析系统及分析方法
KR101974583B1 (ko) 2012-08-29 2019-05-02 삼성전자주식회사 링커 폴리펩티드 및 이를 이용한 표적 물질 분석 방법
EP3641891A4 (en) 2017-06-22 2021-01-27 William Marsh Rice University SYNTHESIS OF DISORAZOLES AND THEIR ANALOGUES AS POWERFUL ANTI-CANCER AGENTS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214969B1 (en) 1988-10-21 2001-04-10 The Administrators Of The Tulane Educational Fund Luteinizing hormone releasing hormone analogs with cytotoxic moiety
US5866679A (en) 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US5843903A (en) 1995-11-27 1998-12-01 The Administrators Of The Tulane Educational Fund Targeted cytotoxic anthracycline analogs
AU715632B2 (en) 1996-09-12 2000-02-03 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
DE19728737C1 (de) 1997-07-04 1999-02-11 Johannes Christian Groeninghen Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten
DE69820644D1 (de) 1997-07-10 2004-01-29 Merck & Co Inc Konjugate welche bei der behandlung von prostatakrebs nützlich sind
CN1678310A (zh) * 2002-08-24 2005-10-05 赞塔里斯有限公司 用于治疗良性和恶性肿瘤疾病的含有disorazole及其衍生物的药物
AU2003298864A1 (en) 2002-12-06 2004-06-30 Kosan Biosciences, Inc. Disorazole polyketide synthase encoding polynucleotides
NZ550934A (en) * 2004-05-19 2010-05-28 Medarex Inc Chemical linkers and conjugates thereof
US20060199252A1 (en) 2005-01-13 2006-09-07 Herbert Irschik Genes encoding the synthetic pathway for the production of disorazole
EP1838848A1 (en) 2005-01-13 2007-10-03 Helmholtz-Zentrum für Infektionsforschung GmbH Genes encoding the synthetic pathway for the production of disorazole
WO2006135371A1 (en) * 2005-06-09 2006-12-21 Kosan Biosciences Incorporated Conjugates with reduced adverse systemic effects
EP1743897A1 (en) * 2005-07-15 2007-01-17 Gesellschaft für Biotechnologische Forschung mbH Biologically active compounds obtainable from Sorangium cellulosum
EP1900742A1 (en) 2006-09-07 2008-03-19 AEterna Zentaris GmbH Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof

Also Published As

Publication number Publication date
AR062685A1 (es) 2008-11-26
KR101532966B1 (ko) 2015-07-02
EP2066679A1 (en) 2009-06-10
US20080090758A1 (en) 2008-04-17
TW200823228A (en) 2008-06-01
US8470776B2 (en) 2013-06-25
WO2008028934A1 (en) 2008-03-13
AU2007293650A1 (en) 2008-03-13
ES2572183T3 (es) 2016-05-30
US20100317580A1 (en) 2010-12-16
KR20090064436A (ko) 2009-06-18
MX2009002483A (es) 2009-03-23
WO2008028934A8 (en) 2008-05-02
US7741277B2 (en) 2010-06-22
AU2007293650B2 (en) 2012-06-14
NZ575032A (en) 2011-02-25
RU2009112546A (ru) 2010-10-20
EP2066679B1 (en) 2016-03-09
CA2662308A1 (en) 2008-03-13
DK2066679T3 (en) 2016-06-27
US20100323963A1 (en) 2010-12-23
TWI346116B (en) 2011-08-01
HUE028061T2 (en) 2016-11-28
SI2066679T1 (sl) 2016-06-30
EP1900742A1 (en) 2008-03-19
PL2066679T3 (pl) 2016-09-30
RS54857B1 (sr) 2016-10-31
CA2662308C (en) 2014-10-28

Similar Documents

Publication Publication Date Title
MX337358B (es) Conjugados de disorazoles y sus derivados con moleculas de union con celulas, nuevos derivados de disorazol, procesos de fabricacion y usos de los mismos.
PH12017501461A1 (en) Antibody drug conjugates (adc) that bind to 191p4d12 proteins
CY1111065T1 (el) Φαρμακευτικη συνθεση που περιεχει μια ωμεγα-καρβοξυαρυλ υποκατεστημενη διφαινυλ ουρια για τη θεραπευτικη αντιμετωπιση του καρκινου
MX358013B (es) Materiales y metodos para el tratamiento o prevencion de enfermedades asociadas al her-3.
CY1119410T1 (el) Βελτιστοποιημενα μονοκλωνικα αντισωματα εναντι του αναστολεα της οδου του ιστικου παραγοντα (tfpi)
CA2818990A1 (en) Designed repeat proteins binding to serum albumin
IL184617A0 (en) Dr5 antibodies and uses thereof
EA201201120A1 (ru) Конъюгаты антитело-лекарственное средство (adc), которые связываются с белками 161p2f10b
MX2010002716A (es) Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
WO2007111661A3 (en) Human antibodies specific for gastrin materials and methods
IL189452A0 (en) Therapy with cd4 binding peptides and radiation
EA201500261A1 (ru) Конъюгаты антитело-лекарственное средство (adc), которые связываются с белками 158p1d7
WO2007125331A3 (en) Amino-ethyl-amino-aryl (aeaa) compounds and their use
UA99601C2 (ru) Применение антитела к cd151 для лечения первичных опухолей
WO2008040190A8 (en) Small peptides for anti-angiogenesis and use thereof
ATE458819T1 (de) Konjugat mit p21-protein zur krebsbehandlung
MX2009012599A (es) Mutantes de vegf-d y su uso.
NO20091239L (no) Konjugater av disorazoler og deres derivater med celle bindingsmolekyler, nye disorazol derivater, fremgangsmate for fremstilling og anvendelse derav
WO2013093122A3 (en) Antibodies for the treatment and diagnosis of affective and anxiety disorders
WO2010094981A3 (en) Antibody therapy
CY1117600T1 (el) Συζυγη διζοραζολιων και παραγωγα τους με μορια κυτταρικης συνδεσης, νεα παραγωγα διζοραζολιου, μεθοδοι παραγωγης και χρησεις τους
AU2017236047B2 (en) Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
DK1962822T3 (da) Terapi af maligne neoplasier
UA97414C2 (ru) Выделенное человеческое антитело, связывающееся с gm-csf
TH141454A (th) แอนติดรักคอนจูเกต (adc) ซึ่งยึดเกาะกับโปรตีน 161p2f10b